References
- Roberts MS, Cross SE. (1999). Percutaneous absorption of topically applied NSAIDS and other compounds: role of solute properties, skin physiology and delivery systems. Inflammopharmacology, 7:339–350.
- Cross SE, Roberts MS. (2004). Physical enhancement of transdermal drug application: is delivery technology keeping up with pharmaceutical development? Curr Drug Deliv, 1:81–92.
- Scheindlin S. (2004). Transdermal drug delivery: Past, Present, Future. Mol Interv, 4:308–312.
- Prausnitz MR, Bose VG, Langer R, Weaver JC. (1993). Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc Natl Acad Sci USA, 90:10504–10508.
- Sintov AC, Krymberk I, Daniel D, Hannan T, Sohn Z, Levin G. (2003). Radiofrequency-driven skin microchanneling as a new way for electrically assisted transdermal delivery of hydrophilic drugs. J Control Release, 89:311–320.
- Kalia YN, Naik A, Garrison J, Guy RH. (2004). Iontophoretic drug delivery. Adv Drug Deliv Rev, 56:619–658.
- Prausnitz MR. (2004). Microneedles for transdermal drug delivery. Adv Drug Deliv Rev, 56:581–587.
- Mitragotri S. (2005). Healing sound: the use of ultrasound in drug delivery and other therapeutic applications. Nat Rev Drug Discov, 4:255–260.
- Trommer H, Neubert RH. (2006). Overcoming the stratum corneum: the modulation of skin penetration. A review. Skin Pharmacol Physiol, 19:106–121.
- Oh SY, Jeong SY, Park TG, Lee JH. (1998). Enhanced transdermal delivery of AZT (Zidovudine) using iontophoresis and penetration enhancer. J Control Release, 51:161–168.
- Ganga S, Ramarao P, Singh J. (1996). Effect of Azone on the iontophoretic transdermal delivery of metoprolol tartrate through human epidermis in vitro. Journal of Controlled Release, 42:57–64.
- Mitragotri S, Ray D, Farrell J, Tang H, Yu B, Kost J et al. (2000). Synergistic effect of low-frequency ultrasound and sodium lauryl sulfate on transdermal transport. J Pharm Sci, 89:892–900.
- Murthy SN, Sammeta SM, Bowers C. (2010). Magnetophoresis for enhancing transdermal drug delivery: Mechanistic studies and patch design. J Control Release, 148:197–203.
- El Maghraby GM, Williams AC, Barry BW. (2001). Skin hydration and possible shunt route penetration in controlled estradiol delivery from ultradeformable and standard liposomes. J Pharm Pharmacol, 53:1311–1322.
- Essa EA, Bonner MC, Barry BW. (2002). Human skin sandwich for assessing shunt route penetration during passive and iontophoretic drug and liposome delivery. J Pharm Pharmacol, 54:1481–1490.
- Sammeta SM, Vaka SR, Murthy SN. (2009). Dermal drug levels of antibiotic (cephalexin) determined by electroporation and transcutaneous sampling (ETS) technique. J Pharm Sci, 98:2677–2685.
- Davies DJ, Ward RJ, Heylings JR. (2004). Multi-species assessment of electrical resistance as a skin integrity marker for in vitro percutaneous absorption studies. Toxicol in Vitro, 18:351–358.
- Padula C, Colombo G, Nicoli S, Catellani PL, Massimo G, Santi P. (2003). Bioadhesive film for the transdermal delivery of lidocaine: in vitro and in vivo behavior. J Control Release, 88:277–285.
- Koizumi A, Fujii M, Kondoh M, Watanabe Y. (2004). Effect of N-methyl-2-pyrrolidone on skin permeation of estradiol. Eur J Pharm Biopharm, 57:473–478.
- Murthy SN, Vaka SR. (2009). Irontophoresis: transdermal delivery of iron by iontophoresis. J Pharm Sci, 98:2670–2676.
- Oertel RP. (1977). Protein conformational changes induced in human stratum corneum by organic sulfoxides: an infrared spectroscopic investigation. Biopolymers, 16:2329–2345.
- Anigbogu ANC, Williams AC, Barry BW, Edwards HGM. (1995). Fourier transform raman spectroscopy of interactions between the penetration enhancer dimethyl sulfoxide and human stratum corneum. International Journal of Pharmaceutics, 125:265–282.
- Williams AC, Barry BW. (2004). Penetration enhancers. Adv Drug Deliv Rev, 56:603–618.
- Chantasart D, Pongjanyakul T, Higuchi WI, Li SK. (2009). Effects of oxygen-containing terpenes as skin permeation enhancers on the lipoidal pathways of human epidermal membrane. J Pharm Sci, 98:3617–3632.
- Williams AC, Barry BW. (1991). The enhancement index concept applied to terpene penetration enhancers for human skin and model lipophilic (oestradiol) and hydrophilic (5-fluorouracil) drugs. International Journal of Pharmaceutics, 74:157–168.
- Kunta JR, Goskonda VR, Brotherton HO, Khan MA, Reddy IK. (1997). Effect of menthol and related terpenes on the percutaneous absorption of propranolol across excised hairless mouse skin. J Pharm Sci, 86:1369–1373.
- Jain AK, Thomas NS, Panchagnula R. (2002). Transdermal drug delivery of imipramine hydrochloride. I. Effect of terpenes. J Control Release, 79:93–101.
- Benson HA. (2005). Transdermal drug delivery: penetration enhancement techniques. Curr Drug Deliv, 2:23–33.
- Yamashita F, Hashida M. (2003). Mechanistic and empirical modeling of skin permeation of drugs. Adv Drug Deliv Rev, 55:1185–1199.
- Barry BW. (2002). Drug delivery routes in skin: a novel approach. Adv Drug Deliv Rev, 54 Suppl 1:S31–S40.